BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 17 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 18 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 19 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 17 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 18 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 19 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
Market News

Luckin Coffee is already pleasing Wall Street analysts

This Chinese company is hardly two years old, it went public less than a month ago, and is already getting on the good side of Wall Street analysts. We are talking about Luckin Coffee (NASDAQ: LK), which, despite being smaller in size, is fast becoming a major competitor to Starbucks (NASDAQ: SBUX). The company offers […]

June 14, 2019 2 min read
Market News

This Chinese company is hardly two years old, it went public less than a month ago, and is already getting on the good side of Wall Street analysts. We are talking about Luckin Coffee (NASDAQ: LK), which, despite being smaller in size, is fast becoming a major competitor to Starbucks (NASDAQ: SBUX). The company offers […]

· June 14, 2019

This Chinese company is hardly two years old, it went public less than a month ago, and is already getting on the good side of Wall Street analysts. We are talking about Luckin Coffee (NASDAQ: LK), which, despite being smaller in size, is fast becoming a major competitor to Starbucks (NASDAQ: SBUX).

The company offers heavy discounts on its coffee, which can be ordered through a mobile app. Its shares have gained 5.6% since the IPO on May 16, when 33 million shares were offered at a price of $17 apiece.

luckin coffee
Image: Luckin Coffee

Three analysts have already expressed positive opinion on the
stock. Eric Gonzalez of KeyBanc has rated the stock overweight, as he feels the
low-budget model and limited competition in the home market will work in favor
of the company.

“Luckin Coffee’s rapid ascent toward becoming one of China’s
largest consumer brands has attracted its fair share of skeptics. However, we
believe the company has several strategic advantages that should support its
transition into a profitable business,” he said.

KeyBlanc has a price target of $22 on the stock, which is at a 22% upside from the last close.

ADVERTISEMENT

READ: Chewy is going public on Friday and investors are thrilled

Meanwhile, Needham analyst Vincent Yu sees the company breaking even as early as the third quarter of this year. However, he does not expect cash-flow break-even until another year.

Needham has a better price target of $27, with a buy rating.

Lillian Lou of Morgan Stanley said, “We expect Luckin’s
implied market share to grow from 1% to 23% in 2018-21. Urbanization and the
increasing adoption of coffee-drinking by younger generations will underpin
this growth.”

However, he warns that the company’s success could depend on a lot of factors including the rising competition, management strategy, and consumer demands. Morgan Stanley has a more cautious price target of $21 on the stock.

ADVERTISEMENT

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT